Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromatin | 16 | 2024 | 2934 | 1.540 |
Why?
|
Chromatin Immunoprecipitation | 16 | 2016 | 893 | 1.110 |
Why?
|
Software | 14 | 2024 | 4442 | 0.990 |
Why?
|
Ascomycota | 1 | 2023 | 82 | 0.870 |
Why?
|
Databases, Protein | 1 | 2024 | 383 | 0.800 |
Why?
|
Transcription Factors | 21 | 2024 | 12207 | 0.690 |
Why?
|
Genomics | 6 | 2024 | 5722 | 0.620 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2022 | 3598 | 0.590 |
Why?
|
Epigenesis, Genetic | 9 | 2023 | 3646 | 0.550 |
Why?
|
Gene Expression Regulation | 14 | 2020 | 12075 | 0.530 |
Why?
|
Sequence Analysis, DNA | 11 | 2024 | 4803 | 0.500 |
Why?
|
Oligonucleotide Array Sequence Analysis | 16 | 2013 | 3921 | 0.480 |
Why?
|
Databases, Genetic | 9 | 2023 | 1782 | 0.470 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2022 | 3617 | 0.470 |
Why?
|
Histones | 11 | 2024 | 2600 | 0.450 |
Why?
|
Computational Biology | 10 | 2021 | 3523 | 0.440 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 8 | 2013 | 170 | 0.430 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3584 | 0.420 |
Why?
|
Nucleosomes | 4 | 2013 | 494 | 0.410 |
Why?
|
Epigenomics | 5 | 2023 | 903 | 0.370 |
Why?
|
Embryonic Development | 2 | 2023 | 711 | 0.310 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2012 | 871 | 0.300 |
Why?
|
Receptors, Androgen | 6 | 2013 | 1057 | 0.270 |
Why?
|
Histone Code | 5 | 2020 | 163 | 0.270 |
Why?
|
Single-Cell Analysis | 4 | 2023 | 2183 | 0.250 |
Why?
|
Models, Biological | 2 | 2020 | 9582 | 0.240 |
Why?
|
Estrogen Receptor alpha | 4 | 2012 | 577 | 0.230 |
Why?
|
Models, Genetic | 6 | 2020 | 3494 | 0.220 |
Why?
|
Histone Demethylases | 2 | 2018 | 321 | 0.210 |
Why?
|
Deoxyribonuclease I | 2 | 2013 | 229 | 0.210 |
Why?
|
Chromatin Assembly and Disassembly | 4 | 2019 | 635 | 0.210 |
Why?
|
Gene Expression Profiling | 10 | 2021 | 9438 | 0.210 |
Why?
|
Genome, Human | 9 | 2016 | 4420 | 0.200 |
Why?
|
Gene Library | 3 | 2021 | 1076 | 0.190 |
Why?
|
Cell Line, Tumor | 18 | 2023 | 16687 | 0.190 |
Why?
|
Enhancer Elements, Genetic | 5 | 2010 | 1341 | 0.190 |
Why?
|
Internet | 4 | 2024 | 3063 | 0.180 |
Why?
|
Biological Assay | 1 | 2023 | 652 | 0.180 |
Why?
|
Deoxyribonucleases | 2 | 2022 | 214 | 0.180 |
Why?
|
Transcription Factor AP-1 | 1 | 2020 | 317 | 0.170 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2021 | 794 | 0.170 |
Why?
|
Chromosome Mapping | 6 | 2016 | 4742 | 0.160 |
Why?
|
Immunotherapy | 3 | 2023 | 4440 | 0.160 |
Why?
|
Algorithms | 6 | 2014 | 13885 | 0.150 |
Why?
|
Transcription, Genetic | 7 | 2020 | 7723 | 0.150 |
Why?
|
Nuclear Proteins | 4 | 2021 | 5853 | 0.150 |
Why?
|
Binding Sites | 8 | 2013 | 6116 | 0.140 |
Why?
|
Histone Deacetylases | 1 | 2020 | 729 | 0.130 |
Why?
|
Cyclin C | 1 | 2014 | 14 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2017 | 8426 | 0.120 |
Why?
|
Protein Binding | 8 | 2020 | 9392 | 0.120 |
Why?
|
Receptors, Estrogen | 4 | 2023 | 2186 | 0.120 |
Why?
|
Receptor, Notch1 | 2 | 2014 | 502 | 0.120 |
Why?
|
Quality Control | 1 | 2016 | 843 | 0.120 |
Why?
|
Azepines | 1 | 2016 | 336 | 0.120 |
Why?
|
Leukemia | 1 | 2022 | 1508 | 0.110 |
Why?
|
Mice | 16 | 2024 | 81178 | 0.110 |
Why?
|
Gene Regulatory Networks | 2 | 2013 | 1708 | 0.110 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2020 | 1821 | 0.110 |
Why?
|
Animals | 20 | 2024 | 168788 | 0.110 |
Why?
|
Homeodomain Proteins | 3 | 2011 | 2422 | 0.110 |
Why?
|
Gene Expression | 3 | 2023 | 7799 | 0.110 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1860 | 0.100 |
Why?
|
Acetylation | 3 | 2020 | 1085 | 0.100 |
Why?
|
Genome | 5 | 2018 | 1808 | 0.100 |
Why?
|
Sequence Analysis, RNA | 3 | 2020 | 2013 | 0.100 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2014 | 671 | 0.100 |
Why?
|
Breast Neoplasms | 8 | 2020 | 20817 | 0.100 |
Why?
|
Dihydrotestosterone | 1 | 2011 | 188 | 0.090 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 407 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4477 | 0.090 |
Why?
|
Neoplasms | 5 | 2022 | 21672 | 0.090 |
Why?
|
Cell Differentiation | 2 | 2022 | 11478 | 0.090 |
Why?
|
Promoter Regions, Genetic | 6 | 2012 | 5867 | 0.090 |
Why?
|
Triazoles | 1 | 2016 | 911 | 0.090 |
Why?
|
RNA Stability | 1 | 2012 | 322 | 0.090 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2009 | 43 | 0.090 |
Why?
|
Humans | 51 | 2024 | 744220 | 0.090 |
Why?
|
Databases, Nucleic Acid | 1 | 2010 | 211 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2016 | 2374 | 0.090 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 491 | 0.080 |
Why?
|
Epithelium | 1 | 2013 | 1680 | 0.080 |
Why?
|
DNA-Binding Proteins | 4 | 2011 | 9647 | 0.080 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2013 | 713 | 0.080 |
Why?
|
Protein Structure, Tertiary | 1 | 2016 | 3846 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2016 | 5169 | 0.080 |
Why?
|
Cyclin D1 | 1 | 2010 | 462 | 0.080 |
Why?
|
Epidermal Growth Factor | 1 | 2010 | 709 | 0.080 |
Why?
|
Macrophages | 1 | 2021 | 5657 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1213 | 0.070 |
Why?
|
Transcriptional Activation | 2 | 2009 | 1782 | 0.070 |
Why?
|
Artifacts | 1 | 2014 | 1903 | 0.070 |
Why?
|
Breast | 2 | 2014 | 1969 | 0.070 |
Why?
|
Lysine | 2 | 2020 | 1008 | 0.070 |
Why?
|
RNA Precursors | 1 | 2006 | 208 | 0.060 |
Why?
|
Response Elements | 1 | 2006 | 311 | 0.060 |
Why?
|
Base Sequence | 5 | 2020 | 12801 | 0.060 |
Why?
|
Genetic Loci | 1 | 2014 | 2575 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5475 | 0.060 |
Why?
|
Transcription Initiation Site | 2 | 2020 | 196 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2010 | 987 | 0.060 |
Why?
|
Prostatic Neoplasms | 4 | 2018 | 11074 | 0.060 |
Why?
|
Exons | 2 | 2007 | 2439 | 0.060 |
Why?
|
RNA, Messenger | 4 | 2013 | 13036 | 0.060 |
Why?
|
Information Storage and Retrieval | 1 | 2009 | 824 | 0.060 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2006 | 436 | 0.060 |
Why?
|
Cell Line | 5 | 2020 | 15999 | 0.050 |
Why?
|
Calcium Signaling | 1 | 2007 | 721 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2021 | 27 | 0.050 |
Why?
|
DNA Copy Number Variations | 1 | 2010 | 1940 | 0.050 |
Why?
|
Epithelial Cells | 2 | 2010 | 3690 | 0.050 |
Why?
|
Intestines | 1 | 2010 | 1924 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2018 | 1655 | 0.050 |
Why?
|
Proteomics | 2 | 2016 | 3637 | 0.050 |
Why?
|
RNA Polymerase II | 1 | 2005 | 551 | 0.050 |
Why?
|
Trans-Activators | 1 | 2010 | 2924 | 0.050 |
Why?
|
Genes, cdc | 1 | 2020 | 116 | 0.050 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2020 | 56 | 0.050 |
Why?
|
DNA Methylation | 1 | 2014 | 4289 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2013 | 2948 | 0.040 |
Why?
|
Phenylenediamines | 1 | 2020 | 90 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13668 | 0.040 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2020 | 168 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2018 | 3557 | 0.040 |
Why?
|
Adenocarcinoma | 2 | 2014 | 6352 | 0.040 |
Why?
|
Acrylamides | 1 | 2020 | 255 | 0.040 |
Why?
|
Chemotaxis | 1 | 2021 | 607 | 0.040 |
Why?
|
Immune Evasion | 1 | 2021 | 360 | 0.040 |
Why?
|
Linear Models | 2 | 2022 | 5953 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2022 | 3461 | 0.040 |
Why?
|
Amino Acid Motifs | 2 | 2013 | 936 | 0.040 |
Why?
|
Estrogens | 3 | 2012 | 1565 | 0.040 |
Why?
|
Chromosomes, Human, Y | 1 | 2018 | 148 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2021 | 1801 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2022 | 817 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2020 | 535 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2018 | 298 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 969 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2006 | 1903 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 15525 | 0.040 |
Why?
|
HeLa Cells | 3 | 2009 | 3129 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2020 | 14556 | 0.030 |
Why?
|
Mediator Complex Subunit 1 | 1 | 2016 | 29 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 21824 | 0.030 |
Why?
|
Phosphoserine | 1 | 2016 | 206 | 0.030 |
Why?
|
Casein Kinase II | 1 | 2016 | 128 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 3 | 1 | 2014 | 11 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2020 | 789 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2014 | 52 | 0.030 |
Why?
|
HL-60 Cells | 1 | 2015 | 365 | 0.030 |
Why?
|
Antigens | 1 | 2020 | 1466 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2016 | 1159 | 0.030 |
Why?
|
Conserved Sequence | 2 | 2009 | 1202 | 0.030 |
Why?
|
Protein Phosphatase 2 | 1 | 2016 | 229 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2006 | 3591 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1877 | 0.030 |
Why?
|
Gene Dosage | 1 | 2018 | 1251 | 0.030 |
Why?
|
Calcium | 1 | 2007 | 5757 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2010 | 18116 | 0.030 |
Why?
|
Down-Regulation | 2 | 2013 | 3001 | 0.030 |
Why?
|
Lung Neoplasms | 2 | 2014 | 13096 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2716 | 0.030 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2012 | 53 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2513 | 0.030 |
Why?
|
Blotting, Western | 2 | 2011 | 5180 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6386 | 0.030 |
Why?
|
Phosphorylation | 2 | 2016 | 8437 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 809 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2020 | 2019 | 0.030 |
Why?
|
K562 Cells | 1 | 2013 | 634 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2018 | 2649 | 0.030 |
Why?
|
Half-Life | 1 | 2012 | 659 | 0.020 |
Why?
|
Nucleotides | 1 | 2013 | 464 | 0.020 |
Why?
|
GATA6 Transcription Factor | 1 | 2010 | 50 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2265 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 733 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 3023 | 0.020 |
Why?
|
Octamer Transcription Factor-1 | 1 | 2010 | 32 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2010 | 117 | 0.020 |
Why?
|
Caco-2 Cells | 1 | 2010 | 387 | 0.020 |
Why?
|
GA-Binding Protein Transcription Factor | 1 | 2009 | 46 | 0.020 |
Why?
|
CREB-Binding Protein | 1 | 2010 | 151 | 0.020 |
Why?
|
Serum Response Factor | 1 | 2009 | 81 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2022 | 4553 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2020 | 5523 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2020 | 1596 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2020 | 3469 | 0.020 |
Why?
|
DNA Polymerase II | 1 | 2009 | 107 | 0.020 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 195 | 0.020 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2009 | 131 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 2432 | 0.020 |
Why?
|
Histone Acetyltransferases | 1 | 2010 | 336 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2009 | 743 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2016 | 10480 | 0.020 |
Why?
|
Neurosecretion | 1 | 2007 | 11 | 0.020 |
Why?
|
Luciferases | 1 | 2009 | 733 | 0.020 |
Why?
|
Neurons | 1 | 2007 | 9335 | 0.020 |
Why?
|
Potassium Chloride | 1 | 2007 | 238 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2020 | 12264 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2715 | 0.020 |
Why?
|
Female | 9 | 2020 | 380197 | 0.020 |
Why?
|
RNA Splice Sites | 1 | 2007 | 209 | 0.020 |
Why?
|
Models, Statistical | 2 | 2014 | 5102 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14726 | 0.020 |
Why?
|
RNA Polymerase III | 1 | 2005 | 51 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2014 | 19227 | 0.020 |
Why?
|
Methylation | 1 | 2008 | 1108 | 0.020 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2005 | 230 | 0.020 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2005 | 351 | 0.020 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2006 | 371 | 0.010 |
Why?
|
High-Throughput Screening Assays | 1 | 2010 | 945 | 0.010 |
Why?
|
Organ Specificity | 1 | 2009 | 2007 | 0.010 |
Why?
|
Microarray Analysis | 1 | 2006 | 766 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2007 | 1137 | 0.010 |
Why?
|
Chromosomes, Human | 1 | 2005 | 457 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2751 | 0.010 |
Why?
|
Genes, p53 | 1 | 2005 | 755 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16365 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18027 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21752 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2010 | 2309 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2204 | 0.010 |
Why?
|
RNA | 1 | 2012 | 2749 | 0.010 |
Why?
|
Models, Molecular | 1 | 2012 | 5458 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2005 | 572 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9735 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5529 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2007 | 1080 | 0.010 |
Why?
|
Ion Channels | 1 | 2007 | 1056 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4752 | 0.010 |
Why?
|
Androgens | 1 | 2009 | 1279 | 0.010 |
Why?
|
Markov Chains | 1 | 2005 | 969 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6367 | 0.010 |
Why?
|
Cell Division | 1 | 2009 | 4567 | 0.010 |
Why?
|
Estradiol | 1 | 2009 | 2020 | 0.010 |
Why?
|
Alternative Splicing | 1 | 2007 | 1118 | 0.010 |
Why?
|
Transfection | 1 | 2009 | 5892 | 0.010 |
Why?
|
DNA | 1 | 2015 | 7303 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3703 | 0.010 |
Why?
|
CpG Islands | 1 | 2005 | 1172 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6313 | 0.010 |
Why?
|
Male | 6 | 2018 | 350027 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2010 | 2416 | 0.010 |
Why?
|
RNA Interference | 1 | 2009 | 2890 | 0.010 |
Why?
|
Cell Lineage | 1 | 2009 | 2504 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2010 | 4841 | 0.010 |
Why?
|
Retina | 1 | 2010 | 2616 | 0.010 |
Why?
|
Signal Transduction | 1 | 2022 | 23404 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6938 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53280 | 0.010 |
Why?
|
Cell Movement | 1 | 2010 | 5216 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29784 | 0.010 |
Why?
|
Cell Membrane | 1 | 2007 | 3748 | 0.010 |
Why?
|
Stem Cells | 1 | 2010 | 3567 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15070 | 0.010 |
Why?
|
MicroRNAs | 1 | 2012 | 3747 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2006 | 2915 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 19907 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2007 | 4465 | 0.010 |
Why?
|
Rats | 1 | 2010 | 24273 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 29050 | 0.010 |
Why?
|